患者安全・リスク管理ソフトウェア市場規模、シェア、動向、2030年までの世界予測

患者安全・リスク管理ソフトウェア市場 – 機能（インシデント報告、コンプライアンス（モニタリング、分析、GRC）、臨床安全（感染管理）、請求管理）、エンドユーザー（病院、ASC、LTC、支払者）、展開、地域別 – 2030年までの世界予測

世界の患者安全・リスク管理ソフトウェア市場は、2025年の17億5,000万米ドルから2030年には29億9,000万米ドルに達し、予測期間中に11.36%という高いCAGRで成長すると予測されています。患者安全・リスク管理ソフトウェア市場は、医療過誤の最小化とケアの質の向上を目指し、世界中の医療システムにとって重要な優先事項として浮上しています。その成長は、有害事象の発生率上昇、医療提供の複雑化、そして価値に基づくケアモデルへの推進によって推進されています。FDA、EMA、合同委員会などの機関による規制枠組みは、厳格な報告、監視、そしてコンプライアンスを義務付けており、医療提供者やライフサイエンス企業は高度なPSRMソリューションの導入を迫られています。同時に、米国保健福祉省の患者安全プログラムやEUの医薬品安全性監視規制といった政府の取り組みも、導入を加速させています。しかし、実装コストの高さ、世界標準化の欠如、従来のシステムとの統合の課題、安全性イベントの報告不足などの障壁により、広範な導入が依然として制限されています。

本レポートは、患者安全・リスク管理ソフトウェア市場を分析し、機能、導入形態、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と将来の成長可能性を予測しています。また、この市場で活動する主要企業の競合分析に加え、各社の企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても提供しています。

本レポートは、既存企業だけでなく新規参入企業や中小企業にとっても、市場の動向を把握し、ひいては市場シェアの拡大に繋がる有益な情報となります。本レポートをご購入いただいた企業は、以下の戦略のいずれか、あるいは組み合わせて活用することで、市場における自社の地位を強化することができます。

The global patient safety and risk software market is projected to reach USD 2.99 billion by 2030 from USD 1.75 billion in 2025, at a high CAGR of 11.36% during the forecast period. The patient safety and risk software market is emerging as a critical priority for healthcare systems worldwide, aimed at minimizing medical errors and improving the quality of care. Its growth is being driven by rising incidences of adverse events, increasing complexity of healthcare delivery, and the push toward value-based care models. Regulatory frameworks from bodies such as the FDA, EMA, and The Joint Commission mandate strict reporting, monitoring, and compliance, compelling providers and life sciences companies to adopt advanced PSRM solutions. At the same time, government initiatives, such as the US Department of Health and Human Services’ patient safety programs and the EU’s pharmacovigilance regulations, are accelerating adoption. However, barriers such as high implementation costs, lack of global standardization, integration challenges with legacy systems, and underreporting of safety events continue to limit widespread adoption.

Compliance & governance under the function segment is expected to register the fastest growth during the forecast period.

The compliance & governance segment is the fastest-growing segment during the forecast period, driven by the rising emphasis on meeting regulatory requirements and maintaining transparency in healthcare operations. Increasing scrutiny from regulatory bodies, coupled with the need for standardized reporting and audit trails, is encouraging healthcare organizations to adopt advanced compliance management solutions. These tools help ensure adherence to quality standards, data protection regulations, and patient safety protocols, thereby supporting risk mitigation and operational efficiency across the healthcare ecosystem.

The cloud-based deployment segment is projected to register the fastest growth during the forecast period.

The cloud-based segment is the fastest-growing segment, driven by the rising adoption of digital health technologies and the shift toward flexible, scalable deployment models. Cloud solutions offer seamless data access, interoperability, and real-time collaboration across healthcare settings, enabling faster decision-making and improved patient safety outcomes. Additionally, lower upfront costs, reduced IT infrastructure requirements, and enhanced data security through advanced encryption and compliance measures are further accelerating the adoption of cloud-based platforms in this market.

Asia Pacific is expected to witness the highest growth rate during the forecast period.

The Asia Pacific region is positioned to register the highest CAGR in the patient safety and risk software market, driven by unprecedented healthcare digitization, government initiatives, and substantial technology investments. For example, the smart hospital program in China aims to upgrade over 1,000 public hospitals by 2025 with integrated IT solutions. The growing burden of medical errors, expansion of healthcare infrastructure, and the push for EHR/EMR integration across emerging economies such as India, China, and Southeast Asia are further fueling adoption. The expanding pharmaceutical and medical device sectors in the region, coupled with a rising patient population, are creating strong demand for efficient risk management and safety solutions.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The breakdown of primary participants is as mentioned below:

• By Company Type – Tier 1: 31%, Tier 2: 28%, and Tier 3: 41%
• By Designation – C Level: 31%, Director Level: 25%, and Others: 44%
• By Region – North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players

The key players operating in the patient safety and risk software market include Riskonnect, Inc. (US), Origami Risk LLC (US), RLDatix (US), Health Catalyst (US), symplr (US), Clarity Group, Inc. (US), Performance Health Partners (US), MorCare, LLC (US), RiskQual Technologies, Inc. (US), Prista Corporation (US), IQVIA Inc. (US), Inovalon (US), NAVEX Global, Inc. (US), Censinet (US), American Data Network (US), Arventa Pty Ltd (Australia), ComplianceQuest (US), Radar Healthcare Inc (UK), Pascal Metrics Inc. (US), and SafeQual Health (US)

Research Coverage

The report analyzes the patient safety and risk software market and estimate the market size and future growth potential of various market segments, based on function, deployment mode,  end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a higher share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.

This report provides insights into:

Analysis of key drivers (rising patient safety incidents, increasing prioritization of patient safety, escalating healthcare costs and shift toward value-based care models, increasing adoption of digital health technologies), restraints (high implementation and maintenance costs, resistance to adoption and perceived complexity of patient safety and risk software, data privacy and interoperability challenges), opportunities (growing adoption of AI, predictive analytics, and automation, increasing adoption of patient safety and risk software into MedTech and pharma safety domains, integration of  patient safety and risk software with population health and real-world evidence platforms), challenges (lack of global standardization in safety reporting, complex integration with legacy systems, limited awareness and underreporting of safety incidents)

•  Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and solution launches in the patient safety and risk software market.
• Market Development: Comprehensive information on the lucrative emerging markets, function, deployment mode, end user, and region
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient safety and risk software market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient safety & risk software market such as Riskonnect, Inc. (US), Origami Risk LLC (US), RLDatix (US), symplr (US), and Radar Healthcare Inc (UK)

Table of Contents

1               INTRODUCTION              32

1.1           STUDY OBJECTIVES       32

1.2           MARKET DEFINITION   32

1.3           STUDY SCOPE   33

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      33

1.3.2        INCLUSIONS AND EXCLUSIONS 34

1.3.3        YEARS CONSIDERED      35

1.4           CURRENCY CONSIDERED            35

1.5           STAKEHOLDERS               35

2               RESEARCH METHODOLOGY       37

2.1           RESEARCH DATA              37

2.1.1        SECONDARY DATA          38

2.1.1.1    Key data from secondary sources       39

2.1.2        PRIMARY DATA 39

2.1.2.1    Key data from primary sources           41

2.1.2.2    Insights from primary experts             41

2.2           MARKET SIZE ESTIMATION         42

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 48

2.4           RESEARCH ASSUMPTIONS           50

2.4.1        MARKET SIZING ASSUMPTIONS                50

2.4.2        OVERALL STUDY ASSUMPTIONS              50

2.5           RESEARCH LIMITATIONS             51

2.5.1        METHODOLOGY-RELATED LIMITATIONS           51

2.5.2        SCOPE-RELATED LIMITATIONS                 51

2.6           RISK ANALYSIS  51

3               EXECUTIVE SUMMARY  52

4               PREMIUM INSIGHTS       56

4.1           PATIENT SAFETY AND RISK SOFTWARE MARKET OVERVIEW          56

4.2           PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER AND REGION                57

4.3           PATIENT SAFETY AND RISK SOFTWARE MARKET: GEOGRAPHIC SNAPSHOT            58

4.4           PATIENT SAFETY AND RISK SOFTWARE MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS              59

5               MARKET OVERVIEW       60

5.1           INTRODUCTION              60

5.2           MARKET DYNAMICS       60

5.2.1        DRIVERS               62

5.2.1.1    Rising patient safety incidents            62

5.2.1.2    Increasing prioritization of patient safety         63

5.2.1.3    Escalating healthcare costs and shift toward value-based care models    63

5.2.1.4    Increasing adoption of digital health technologies          64

5.2.2        RESTRAINTS      64

5.2.2.1    High implementation and maintenance costs 64

5.2.2.2    Resistance to adoption and perceived complexity of patient safety and risk software   65

5.2.2.3    Data privacy and interoperability challenges   65

5.2.3        OPPORTUNITIES              67

5.2.3.1    Growing adoption of AI, predictive analytics, and automation                 67

5.2.3.2    Increasing adoption of patient safety and risk solutions into MedTech and pharma safety domains               67

5.2.3.3    Integration of patient safety and risk software with population health and real-world evidence platforms         68

5.2.4        CHALLENGES    68

5.2.4.1    Lack of global standardization in safety reporting           68

5.2.4.2    Complex integration with legacy systems         68

5.2.4.3    Limited awareness and underreporting of safety events                 69

5.3           INDUSTRY TRENDS         69

5.3.1        MOBILE HEALTH PLATFORMS   69

5.3.2        CLOUD-BASED ALARM MANAGEMENT SOLUTION                 69

5.3.3        IOT-ENABLED SOLUTIONS         69

5.4           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS            70

5.5           PRICING ANALYSIS          70

5.5.1        INDICATIVE PRICING ANALYSIS, BY KEY PLAYER                 71

5.5.2        INDICATIVE PRICING ANALYSIS, BY REGION      71

5.6           VALUE CHAIN ANALYSIS               72

5.7           ECOSYSTEM ANALYSIS  73

5.8           INVESTMENT AND FUNDING SCENARIO               76

5.9           TECHNOLOGY ANALYSIS             76

5.9.1        KEY TECHNOLOGIES     76

5.9.1.1    AI-powered risk scoring      76

5.9.1.2    Automated root cause analysis           77

5.9.1.3    Real-time safety dashboards               77

5.9.1.4    Mobile incident reporting apps          77

5.9.2        ADJACENT TECHNOLOGIES       77

5.9.2.1    Cloud SaaS platforms           78

5.9.2.2    Blockchain             78

5.9.3        COMPLEMENTARY TECHNOLOGIES       78

5.9.3.1    EHR/EMR integration         78

5.9.3.2    Claims and billing systems  78

5.9.3.3    Credentialing systems          79

5.10         PATENT ANALYSIS          79

5.10.1      PATENT PUBLICATION TREND 79

5.10.2      LIST OF PATENTS            81

5.11         KEY CONFERENCES AND EVENTS, 2025–2027        82

5.12         CASE STUDY ANALYSIS 83

5.12.1      ADOPTION OF VIRTUAL OBSERVATION SOLUTION TO REDUCE FALL

RATES IN PATIENTS       83

5.12.2      UTILIZATION OF ENTERPRISE RISK MANAGEMENT SYSTEM FOR ENHANCED PATIENT SAFETY         83

5.12.3      USE OF COMPREHENSIVE HEALTHCARE RISK MANAGEMENT SOFTWARE

FOR IMPROVED REGULATORY COMPLIANCE  84

5.13         REGULATORY LANDSCAPE         84

5.13.1      REGULATORY ANALYSIS               84

5.13.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             89

5.14         PORTER’S FIVE FORCES ANALYSIS           92

5.14.1      BARGAINING POWER OF SUPPLIERS       93

5.14.2      BARGAINING POWER OF BUYERS             93

5.14.3      THREAT OF NEW ENTRANTS      93

5.14.4      THREAT OF SUBSTITUTES          93

5.14.5      INTENSITY OF COMPETITIVE RIVALRY 93

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     94

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           94

5.15.2      BUYING CRITERIA           95

5.16         END-USER ANALYSIS      95

5.16.1      UNMET NEEDS 95

5.16.2      END-USER EXPECTATIONS         96

5.17         BUSINESS MODEL            97

5.17.1      SUBSCRIPTION LICENSING         97

5.17.2      MODULAR PLATFORM APPROACH          97

5.17.3      IMPLEMENTATION AND INTEGRATION FEES    97

5.17.4      VALUE-ADDED SERVICES             97

5.17.5      MARKETPLACE INTEGRATION AND REGIONAL PRICING               97

5.18         IMPACT OF AI/GEN AI ON PATIENT SAFETY AND RISK SOFTWARE MARKET       98

5.18.1      INTRODUCTION              98

5.18.2      TOP USE CASES AND MARKET POTENTIAL          98

5.18.3      KEY USE CASES 99

5.18.4      CASE STUDY ON AI/GENERATIVE AI IMPLEMENTATION                 100

5.18.4.1  Use of AI-powered data extraction platform with risk management software          100

5.18.5      INTERCONNECTED AND ADJACENT ECOSYSTEMS                 101

5.18.5.1  Pharmacovigilance and drug safety monitoring               101

5.18.5.2  Healthcare information exchange      101

5.18.5.3  Quality improvement software           102

5.18.5.4  Healthcare GRC   102

5.18.6      USER READINESS AND IMPACT ASSESSMENT     102

5.18.6.1  Healthcare providers            102

5.18.6.2  Pharmaceutical & biotechnology companies    103

5.19         IMPACT OF 2025 US TARIFF         104

5.19.1      INTRODUCTION              104

5.19.2      KEY TARIFF RATES          105

5.19.3      PRICE IMPACT ANALYSIS             105

5.19.4      IMPACT ON COUNTRY/REGION                106

5.19.4.1  US           106

5.19.4.2  Europe   107

5.19.4.3  Asia Pacific            107

5.19.5      IMPACT ON END-USE INDUSTRIES          107

6               PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION          109

6.1           INTRODUCTION              110

6.2           RISK & SAFETY MANAGEMENT  110

6.2.1        INCIDENT REPORTING SYSTEMS              111

6.2.1.1    Need for real-time reporting and automated workflows to support growth    111

6.2.2        EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE         112

6.2.2.1    Ability to analyze incident patterns and implement risk mitigation to promote growth             112

6.2.3        PATIENT LEARNING SYSTEMS   113

6.2.3.1    Increasing focus on improving patient safety to foster growth                 113

6.3           COMPLIANCE & GOVERNANCE 114

6.3.1        RISK/COMPLIANCE MONITORING AND ANALYTICS SOFTWARE         115

6.3.1.1    Evolving need for continuous surveillance of organizational activities to aid growth         115

6.3.2        GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS                 116

6.3.2.1    Growing shift from reactive compliance management to proactive risk prevention to boost market          116

6.4           CLINICAL SAFETY CONTROLS   117

6.4.1        MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE         118

6.4.1.1    Need to prevent medication errors to contribute to growth                 118

6.4.2        INFECTION CONTROL SYSTEMS               119

6.4.2.1    Rise in proactive surveillance, rapid intervention, and

continuous monitoring to expedite growth      119

6.5           FINANCIAL & LEGAL RISK HANDLING    120

6.5.1        CLAIMS MANAGEMENT SOLUTIONS       121

6.5.1.1    Need to leverage data-driven claims management to

minimize costs to favor growth           121

6.5.2        REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS        122

6.5.2.1    Growing focus on minimizing financial and legal risks to propel market    122

7               PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE    123

7.1           INTRODUCTION              124

7.2           ON-PREMISE DEPLOYMENT       124

7.2.1        HIGHER CONTROL, SECURITY, AND CUSTOMIZATION TO BOLSTER GROWTH 124

7.3           CLOUD-BASED DEPLOYMENT  125

7.3.1        NEED TO REDUCE IT OVERHEAD AND ENABLE FASTER INNOVATION

TO SPUR GROWTH          125

7.4           HYBRID DEPLOYMENT 126

7.4.1        ABILITY TO SUPPORT REAL-TIME INCIDENT REPORTING, ROOT CAUSE ANALYSIS, AND COMPLIANCE MONITORING TO DRIVE MARKET            126

8               PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER            128

8.1           INTRODUCTION              129

8.2           HEALTHCARE PROVIDERS           129

8.2.1        HOSPITALS         130

8.2.1.1    Rising demand for high-quality care and patient safety to accelerate growth 130

8.2.2        CLINICS                131

8.2.2.1    Increasing demand for quality care in outpatient and ambulatory settings to facilitate growth 131

8.2.3        AMBULATORY CARE CENTERS  132

8.2.3.1    Growing shift toward outpatient and value-based care models to drive market          132

8.2.4        LONG-TERM CARE CENTERS      133

8.2.4.1    Increasing focus on elderly care and patients with chronic conditions to aid growth      133

8.2.5        PHARMACIES     134

8.2.5.1    Enhanced medical safety and regulatory compliance to augment growth    134

8.2.6        OTHER HEALTHCARE PROVIDERS           135

8.3           PHARMACEUTICAL & BIOTECH COMPANIES      136

8.3.1        NEED TO MAINTAIN PRODUCT QUALITY, REGULATORY COMPLIANCE,

AND PHARMACOVIGILANCE TO ENCOURAGE GROWTH                 136

8.4           HEALTHCARE PAYERS   137

8.4.1        INCREASING ADOPTION OF PATIENT SAFETY AND RISK SOFTWARE FOR ENHANCED QUALITY ACROSS HEALTHCARE ECOSYSTEM TO AID GROWTH  137

8.5           MEDTECH COMPANIES 138

8.5.1        GROWING RISK OF DATA INTEGRITY AND CYBERSECURITY TO FUEL MARKET        138

8.6           OTHER END USERS         139

9               PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION                140

9.1           INTRODUCTION              141

9.2           NORTH AMERICA             141

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 142

9.2.2        US           147

9.2.2.1    Increasing initiatives for improving patient and healthcare workforce safety to aid growth            147

9.2.3        CANADA               151

9.2.3.1    Rise in patient safety improvement programs to contribute to growth    151

9.3           EUROPE               155

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      155

9.3.2        GERMANY           160

9.3.2.1    Targeted government policies and push toward modernizing healthcare delivery to propel market 160

9.3.3        UK          164

9.3.3.1    Growing initiatives on improving patient outcomes and reducing medical errors to drive market            164

9.3.4        FRANCE                168

9.3.4.1    Increasing use of integrated digital platforms in hospitals to expedite growth    168

9.3.5        ITALY    172

9.3.5.1    Favorable national legislation and regional healthcare policies to promote growth    172

9.3.6        SPAIN    176

9.3.6.1    Rising commitment toward enhanced healthcare quality and culture of safety to aid growth            176

9.3.7        REST OF EUROPE             180

9.4           ASIA PACIFIC     184

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 184

9.4.2        CHINA  190

9.4.2.1    Increasing deployment of critical incident reporting systems and EHR-linked safety modules to fuel market       190

9.4.3        JAPAN   194

9.4.3.1    Growing focus on supporting error reporting, root cause analysis,

and clinical protocols to boost market               194

9.4.4        INDIA    198

9.4.4.1    Strong public-private sector initiatives to support growth                 198

9.4.5        AUSTRALIA         202

9.4.5.1    Increasing emphasis on quality improvement across public

and private hospitals to spur growth 202

9.4.6        SOUTH KOREA  205

9.4.6.1    Innovation-driven healthcare ecosystem to facilitate growth                 205

9.4.7        REST OF ASIA PACIFIC   210

9.5           LATIN AMERICA                214

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 214

9.5.2        BRAZIL 219

9.5.2.1    Increasing focus on reducing adverse events and hospital-acquired infections to encourage growth          219

9.5.3        MEXICO                223

9.5.3.1    Expanding healthcare digitization and national policies promoting patient safety to drive market          223

9.5.4        REST OF LATIN AMERICA             227

9.6           MIDDLE EAST & AFRICA                231

9.6.1        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 231

9.6.2        GCC COUNTRIES              235

9.6.2.1    Saudi Arabia          240

9.6.2.1.1 Increasing modernization efforts in healthcare to accelerate growth    240

9.6.2.2    UAE        243

9.6.2.2.1 Evolving digital health landscape to favor growth           243

9.6.2.3    Rest of GCC countries         248

9.6.3        SOUTH AFRICA 252

9.6.3.1    Increasing awareness about patient safety in public and private healthcare sectors to boost market    252

9.6.4        REST OF MIDDLE EAST & AFRICA             256

10            COMPETITIVE LANDSCAPE         260

10.1         INTRODUCTION              260

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            260

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET        260

10.3         REVENUE SHARE ANALYSIS, 2020–2024    262

10.4         MARKET SHARE ANALYSIS, 2024                 263

10.5         BRAND/SOFTWARE COMPARISON           266

10.6         COMPANY VALUATION AND FINANCIAL METRICS                 267

10.6.1      COMPANY VALUATION 267

10.6.2      FINANCIAL METRICS      267

10.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 268

10.7.1      STARS   268

10.7.2      EMERGING LEADERS     268

10.7.3      PERVASIVE PLAYERS      268

10.7.4      PARTICIPANTS 268

10.7.5      COMPANY FOOTPRINT, 2024      270

10.7.5.1  Company footprint               270

10.7.5.2  Region footprint   271

10.7.5.3  Deployment mode footprint                272

10.7.5.4  Function footprint                273

10.7.5.5  End-user footprint                274

10.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        275

10.8.1      PROGRESSIVE COMPANIES         275

10.8.2      RESPONSIVE COMPANIES            275

10.8.3      DYNAMIC COMPANIES  275

10.8.4      STARTING BLOCKS         275

10.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 277

10.8.5.1  Detailed list of key startups/SMEs    277

10.8.5.2  Competitive benchmarking of key startups/SMEs          277

10.9         COMPETITIVE SCENARIO             278

10.9.1      SOLUTION LAUNCHES AND ENHANCEMENTS   278

10.9.2      DEALS  279

10.9.3      EXPANSIONS     280

11            COMPANY PROFILES      281

11.1         KEY PLAYERS     281

11.1.1      RISKONNECT, INC.          281

11.1.1.1  Business overview 281

11.1.1.2  Solutions offered  282

11.1.1.3  Recent developments           282

11.1.1.3.1                Solution launches and enhancements                282

11.1.1.3.2                Deals      283

11.1.1.4  MnM view              283

11.1.1.4.1                Right to win           283

11.1.1.4.2                Strategic choices   283

11.1.1.4.3                Weaknesses and competitive threats 283

11.1.2      ORIGAMI RISK LLC          284

11.1.2.1  Business overview 284

11.1.2.2  Solutions offered  284

11.1.2.3  Recent developments           285

11.1.2.3.1                Solution launches and enhancements                285

11.1.2.4  MnM view              285

11.1.2.4.1                Right to win           285

11.1.2.4.2                Strategic choices   285

11.1.2.4.3                Weaknesses and competitive threats 286

11.1.3      RLDATIX              287

11.1.3.1  Business overview 287

11.1.3.2  Solutions offered  287

11.1.3.3  Recent developments           288

11.1.3.3.1                Solution launches and enhancements                288

11.1.3.3.2                Deals      289

11.1.3.3.3                Expansions             291

11.1.3.4  MnM view              291

11.1.3.4.1                Right to win           291

11.1.3.4.2                Strategic choices   291

11.1.3.4.3                Weaknesses and competitive threats 291

11.1.4      HEALTH CATALYST        292

11.1.4.1  Business overview 292

11.1.4.2  Solutions offered  293

11.1.4.3  Recent developments           294

11.1.4.3.1                Solution launches and enhancements                294

11.1.4.3.2                Deals      294

11.1.5      SYMPLR                297

11.1.5.1  Business overview 297

11.1.5.2  Solutions offered  297

11.1.5.3  Recent developments           298

11.1.5.3.1                Solution launches and enhancements                298

11.1.5.3.2                Deals      298

11.1.5.4  MnM view              299

11.1.5.4.1                Right to win           299

11.1.5.4.2                Strategic choices   299

11.1.5.4.3                Weaknesses and competitive threats 299

11.1.6      CLARITY GROUP, INC.   300

11.1.6.1  Business overview 300

11.1.6.2  Solutions offered  300

11.1.7      PERFORMANCE HEALTH PARTNERS       301

11.1.7.1  Business overview 301

11.1.7.2  Solutions offered  301

11.1.7.3  Recent developments           302

11.1.7.3.1                Deals      302

11.1.8      MORCARE            303

11.1.8.1  Business overview 303

11.1.8.2  Solutions offered  303

11.1.9      RISKQUAL TECHNOLOGIES, INC.              304

11.1.9.1  Business overview 304

11.1.9.2  Solutions offered  304

11.1.10   PRISTA CORPORATION 305

11.1.10.1                 Business overview 305

11.1.10.2                 Solutions offered  305

11.1.11   SAFEQUAL          306

11.1.11.1                 Business overview 306

11.1.11.2                 Solutions offered  306

11.1.12   IQVIA    307

11.1.12.1                 Business overview 307

11.1.12.2                 Solutions offered  308

11.1.12.3                 Recent developments           309

11.1.12.3.1             Solution launches and enhancements                309

11.1.12.3.2             Deals      309

11.1.13   INOVALON         310

11.1.13.1                 Business overview 310

11.1.13.2                 Solutions offered  310

11.1.13.3                 Recent developments           311

11.1.13.3.1             Solution launches and enhancements                311

11.1.14   NAVEX GLOBAL, INC.     312

11.1.14.1                 Business overview 312

11.1.14.2                 Solutions offered  312

11.1.14.3                 Recent developments           313

11.1.14.3.1             Solution launches and enhancements                313

11.1.14.3.2             Deals      314

11.1.14.3.3             Expansions             314

11.1.15   CENSINET           315

11.1.15.1                 Business overview 315

11.1.15.2                 Solutions offered  315

11.1.15.3                 Recent developments           316

11.1.15.3.1             Solution launches and enhancements                316

11.1.16   AMERICAN DATA NETWORK      317

11.1.16.1                 Business overview 317

11.1.16.2                 Solutions offered  317

11.1.17   ARVENTA             318

11.1.17.1                 Business overview 318

11.1.17.2                 Solutions offered  318

11.1.18   COMPLIANCEQUEST     319

11.1.18.1                 Business overview 319

11.1.18.2                 Solutions offered  319

11.1.18.3                 Recent developments           320

11.1.18.3.1             Solution launches and enhancements                320

11.1.18.3.2             Deals      320

11.1.19   RADAR HEALTHCARE INC            321

11.1.19.1                 Business overview 321

11.1.19.2                 Solutions offered  321

11.1.20   PASCAL METRICS INC.   322

11.1.20.1                 Business overview 322

11.1.20.2                 Solutions offered  322

11.2         OTHER PLAYERS              323

11.2.1      OMNIGO              323

11.2.2      LOGICMANAGER, INC.  324

11.2.3      DEXUR 325

11.2.4      HEALTHCARE GRC PTE LTD.      326

11.2.5      NOSOTECH INC.               327

12            APPENDIX           328

12.1         DISCUSSION GUIDE        328

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                333

12.3         CUSTOMIZATION OPTIONS        335

12.4         RELATED REPORTS         335

12.5         AUTHOR DETAILS           336

LIST OF TABLES

TABLE 1                FACTOR ANALYSIS          46

TABLE 2                PATIENT SAFETY AND RISK SOFTWARE MARKET: RISK ANALYSIS              51

TABLE 3                PATIENT SAFETY AND RISK SOFTWARE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS     61

TABLE 4                NORTH AMERICA: HEALTHCARE DATA BREACHES, 2021–2025     65

TABLE 5                INDICATIVE PRICING ANALYSIS OF PATIENT SAFETY AND RISK SOFTWARE,

BY KEY PLAYER, 2024 (USD)         71

TABLE 6                PATIENT SAFETY AND RISK SOFTWARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM                75

TABLE 7                PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION ANALYSIS

OF TOP APPLICANT COUNTRIES, JANUARY 2022–SEPTEMBER 2025        80

TABLE 8                PATIENT SAFETY AND RISK SOFTWARE MARKET: LIST OF PATENTS, JANUARY 2022–SEPTEMBER 2025                 81

TABLE 9                PATIENT SAFETY AND RISK SOFTWARE MARKET: KEY CONFERENCES AND EVENTS, 2025–2027   82

TABLE 10              REGULATORY SCENARIO IN NORTH AMERICA                 84

TABLE 11              REGULATORY SCENARIO IN EUROPE     86

TABLE 12              REGULATORY SCENARIO IN ASIA PACIFIC                 86

TABLE 13              REGULATORY SCENARIO IN MIDDLE EAST & AFRICA 88

TABLE 14              REGULATORY SCENARIO IN LATIN AMERICA                 88

TABLE 15              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  89

TABLE 16              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 90

TABLE 17              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

TABLE 18              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

TABLE 19              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  92

TABLE 20              PATIENT SAFETY AND RISK SOFTWARE MARKET: PORTER’S

FIVE FORCES ANALYSIS 93

TABLE 21              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS  94

TABLE 22              KEY BUYING CRITERIA FOR TOP THREE END USERS   95

TABLE 23              PATIENT SAFETY AND RISK SOFTWARE MARKET: UNMET NEEDS              96

TABLE 24              PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER EXPECTATIONS     96

TABLE 25              US ADJUSTED RECIPROCAL TARIFF RATES                 105

TABLE 26              PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            110

TABLE 27              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 111

TABLE 28              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY REGION, 2023–2030 (USD MILLION)       111

TABLE 29              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INCIDENT REPORTING SYSTEMS, BY REGION, 2023–2030 (USD MILLION)            112

TABLE 30              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE, BY REGION, 2023–2030 (USD MILLION)          113

TABLE 31              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PATIENT LEARNING SYSTEMS, BY REGION, 2023–2030 (USD MILLION)       114

TABLE 32              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       114

TABLE 33              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY REGION, 2023–2030 (USD MILLION)       115

TABLE 34              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK/COMPLIANCE MONITORING & ANALYTICS SOFTWARE, BY REGION, 2023–2030 (USD MILLION)          116

TABLE 35              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS, BY REGION, 2023–2030 (USD MILLION)       117

TABLE 36              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 117

TABLE 37              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY REGION, 2023–2030 (USD MILLION)       118

TABLE 38              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE, BY REGION, 2023–2030 (USD MILLION)                 119

TABLE 39              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INFECTION CONTROL SYSTEMS, BY REGION, 2023–2030 (USD MILLION)            120

TABLE 40              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL &

LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                 120

TABLE 41              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL &

LEGAL RISK HANDLING, BY REGION, 2023–2030 (USD MILLION)                 121

TABLE 42              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLAIMS MANAGEMENT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)            121

TABLE 43              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)        122

TABLE 44              PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 124

TABLE 45              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR ON-PREMISE DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION)       125

TABLE 46              PATIENT SAFETY & RISK SOFTWARE MARKET FOR CLOUD-BASED DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION)            126

TABLE 47              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HYBRID DEPLOYMENT,

BY REGION, 2023–2030 (USD MILLION)   127

TABLE 48              PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            129

TABLE 49              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         130

TABLE 50              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS,

BY REGION, 2023–2030 (USD MILLION)   130

TABLE 51              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)            131

TABLE 52              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICS, BY REGION,

2023–2030 (USD MILLION)            132

TABLE 53              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION)       133

TABLE 54              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR LONG-TERM CARE

CENTERS, BY REGION, 2023–2030 (USD MILLION)              134

TABLE 55              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACIES, BY REGION, 2023–2030 (USD MILLION)            135

TABLE 56              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION)            136

TABLE 57              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION)          137

TABLE 58              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PAYERS,

BY REGION, 2023–2030 (USD MILLION)   138

TABLE 59              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDTECH COMPANIES,

BY REGION, 2023–2030 (USD MILLION)   139

TABLE 60              PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER END USERS,

BY REGION, 2023–2030 (USD MILLION)   139

TABLE 61              PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION,

2023–2030 (USD MILLION)            141

TABLE 62              NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 143

TABLE 63              NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)                 143

TABLE 64              NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                144

TABLE 65              NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                144

TABLE 66              NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                145

TABLE 67              NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)         145

TABLE 68              NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)        146

TABLE 69              NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               146

TABLE 70              NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION)              147

TABLE 71              KEY ACTIVITIES IN US PATIENT SAFETY AND RISK MANAGEMENT

SOFTWARE MARKET       148

TABLE 72              US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            148

TABLE 73              US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 148

TABLE 74              US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       149

TABLE 75              US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 149

TABLE 76              US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL &

LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                 149

TABLE 77              US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 150

TABLE 78              US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)             150

TABLE 79              US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            151

TABLE 80              CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET,

BY FUNCTION, 2023–2030(USD MILLION)              152

TABLE 81              CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET

FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION)            152

TABLE 82              CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030(USD MILLION)          153

TABLE 83              CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030(USD MILLION) 153

TABLE 84              CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030(USD MILLION)          153

TABLE 85              CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            154

TABLE 86              CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030(USD MILLION)              154

TABLE 87              CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION)                155

TABLE 88              EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY,

2023–2030(USD MILLION)              156

TABLE 89              EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030(USD MILLION)              156

TABLE 90              EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION) 157

TABLE 91              EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030(USD MILLION) 157

TABLE 92              EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030(USD MILLION) 158

TABLE 93              EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030(USD MILLION)          158

TABLE 94              EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            158

TABLE 95              EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030(USD MILLION)              159

TABLE 96              EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION)              159

TABLE 97              GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030(USD MILLION)              160

TABLE 98              GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION) 161

TABLE 99              GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                161

TABLE 100            GERMANY: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                162

TABLE 101            GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)         162

TABLE 102            GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            162

TABLE 103            GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            163

TABLE 104            GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            163

TABLE 105            UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            164

TABLE 106            UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 165

TABLE 107            UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       165

TABLE 108            UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 166

TABLE 109            UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL &

LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                 166

TABLE 110            UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 166

TABLE 111            UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            167

TABLE 112            UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 167

TABLE 113            FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            168

TABLE 114            FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                169

TABLE 115            FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                169

TABLE 116            FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                170

TABLE 117            FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)         170

TABLE 118            FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            170

TABLE 119            FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            171

TABLE 120            FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            171

TABLE 121            ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            172

TABLE 122            ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 173

TABLE 123            ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       173

TABLE 124            ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 174

TABLE 125            ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)            174

TABLE 126            ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 174

TABLE 127            ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            175

TABLE 128            ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 175

TABLE 129            SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            176

TABLE 130            SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 177

TABLE 131            SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       177

TABLE 132            SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 178

TABLE 133            SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL &

LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                 178

TABLE 134            SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 178

TABLE 135            SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            179

TABLE 136            SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 179

TABLE 137            REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)                 180

TABLE 138            REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)            181

TABLE 139            REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                181

TABLE 140            REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR

CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)            182

TABLE 141            REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR

FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)            182

TABLE 142            REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)        182

TABLE 143            REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               183

TABLE 144            REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            183

TABLE 145            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 185

TABLE 146            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)                 186

TABLE 147            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR

RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)            186

TABLE 148            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                187

TABLE 149            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                187

TABLE 150            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)         188

TABLE 151            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            188

TABLE 152            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               189

TABLE 153            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            189

TABLE 154            CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            190

TABLE 155            CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 191

TABLE 156            CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       191

TABLE 157            CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 192

TABLE 158            CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)            192

TABLE 159            CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 192

TABLE 160            CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)          193

TABLE 161            CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 193

TABLE 162            JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            194

TABLE 163            JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 195

TABLE 164            JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       195

TABLE 165            JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 196

TABLE 166            JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)            196

TABLE 167            JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 196

TABLE 168            JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            197

TABLE 169            JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 197

TABLE 170            INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            198

TABLE 171            INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 199

TABLE 172            INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       199

TABLE 173            INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 200

TABLE 174            INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL &

LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                 200

TABLE 175            INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 200

TABLE 176            INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            201

TABLE 177            INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 201

TABLE 178            AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            202

TABLE 179            AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK &

SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                 203

TABLE 180            AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                203

TABLE 181            AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL

SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                 204

TABLE 182            AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)         204

TABLE 183            AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            204

TABLE 184            AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            205

TABLE 185            AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            205

TABLE 186            SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)                 206

TABLE 187            SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                206

TABLE 188            SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                207

TABLE 189            SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                207

TABLE 190            SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)         208

TABLE 191            SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            208

TABLE 192            SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)                 209

TABLE 193            SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            209

TABLE 194            REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             210

TABLE 195            REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)        211

TABLE 196            REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)         211

TABLE 197            REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)         212

TABLE 198            REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                212

TABLE 199            REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)        212

TABLE 200            REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               213

TABLE 201            REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)                213

TABLE 202            LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               214

TABLE 203            LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             215

TABLE 204            LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)            215

TABLE 205            LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                216

TABLE 206            LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)            216

TABLE 207            LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 217

TABLE 208            LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            217

TABLE 209            LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               218

TABLE 210            LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            218

TABLE 211            BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            219

TABLE 212            BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 220

TABLE 213            BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       220

TABLE 214            BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 221

TABLE 215            BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)            221

TABLE 216            BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 221

TABLE 217            BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            222

TABLE 218            BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 222

TABLE 219            MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            223

TABLE 220            MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                224

TABLE 221            MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                224

TABLE 222            MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                225

TABLE 223            MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL &

LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                 225

TABLE 224            MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            225

TABLE 225            MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            226

TABLE 226            MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            226

TABLE 227            REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             227

TABLE 228            REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)        228

TABLE 229            REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)         228

TABLE 230            REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                229

TABLE 231            REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                229

TABLE 232            REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)        229

TABLE 233            REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               230

TABLE 234            REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            230

TABLE 235            MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               232

TABLE 236            MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             232

TABLE 237            MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)            233

TABLE 238            MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)            233

TABLE 239            MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)            234

TABLE 240            MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                234

TABLE 241            MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)        234

TABLE 242            MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               235

TABLE 243            MIDDLE EAST AND AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            235

TABLE 244            GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 236

TABLE 245            GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)                 236

TABLE 246            GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR

RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)            237

TABLE 247            GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                237

TABLE 248            GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                238

TABLE 249            GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)         238

TABLE 250            GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)        238

TABLE 251            GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               239

TABLE 252            GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            239

TABLE 253            SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)             240

TABLE 254            SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                241

TABLE 255            SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                241

TABLE 256            SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                242

TABLE 257            SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                242

TABLE 258            SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)        242

TABLE 259            SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               243

TABLE 260            SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET

FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            243

TABLE 261            UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2023–2030 (USD MILLION)            244

TABLE 262            UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND

SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                 244

TABLE 263            UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)       245

TABLE 264            UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL

SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                 245

TABLE 265            UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL

AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)            246

TABLE 266            UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)                 246

TABLE 267            UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2023–2030 (USD MILLION)            247

TABLE 268            UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 247

TABLE 269            REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY FUNCTION, 2023–2030 (USD MILLION)           248

TABLE 270            REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)        249

TABLE 271            REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)         249

TABLE 272            REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                250

TABLE 273            REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                250

TABLE 274            REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)        250

TABLE 275            REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               251

TABLE 276            REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)         251

TABLE 277            SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)                 252

TABLE 278            SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)                253

TABLE 279            SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)                253

TABLE 280            SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                254

TABLE 281            SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)         254

TABLE 282            SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)            254

TABLE 283            SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)                 255

TABLE 284            SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            255

TABLE 285            REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)       256

TABLE 286            REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)        257

TABLE 287            REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)         257

TABLE 288            REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)                258

TABLE 289            REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)                 258

TABLE 290            REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)             258

TABLE 291            REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 259

TABLE 292            REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)               259

TABLE 293            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, JANUARY 2022–SEPTEMBER 2025                260

TABLE 294            PATIENT SAFETY AND RISK SOFTWARE MARKET: DEGREE OF COMPETITION    264

TABLE 295            PATIENT SAFETY AND RISK SOFTWARE MARKET: REGION FOOTPRINT 271

TABLE 296            PATIENT SAFETY AND RISK SOFTWARE MARKET: DEPLOYMENT MODE FOOTPRINT      272

TABLE 297            PATIENT SAFETY AND RISK SOFTWARE MARKET: FUNCTION FOOTPRINT            273

TABLE 298            PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER FOOTPRINT             274

TABLE 299            PATIENT SAFETY AND RISK SOFTWARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS                 277

TABLE 300            PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES              277

TABLE 301            PATIENT SAFETY AND RISK SOFTWARE MARKET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025                278

TABLE 302            PATIENT SAFETY AND RISK SOFTWARE MARKET: DEALS,

JANUARY 2022–SEPTEMBER 2025                279

TABLE 303            PATIENT SAFETY AND RISK SOFTWARE MARKET: EXPANSIONS,

JANUARY 2022–AUGUST 2025     280

TABLE 304            RISKONNECT, INC.: COMPANY OVERVIEW                 281

TABLE 305            RISKONNECT, INC.: SOLUTIONS OFFERED                 282

TABLE 306            RISKONNECT, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                282

TABLE 307            RISKONNECT, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025              283

TABLE 308            ORIGAMI RISK LLC: COMPANY OVERVIEW                 284

TABLE 309            ORIGAMI RISK LLC: SOLUTIONS OFFERED                 284

TABLE 310            ORIGAMI RISK LLC: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                285

TABLE 311            RLDATIX: COMPANY OVERVIEW               287

TABLE 312            RLDATIX: SOLUTIONS OFFERED               287

TABLE 313            RLDATIX: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                288

TABLE 314            RLDATIX: DEALS, JANUARY 2022–SEPTEMBER 2025        289

TABLE 315            RLDATIX: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025              291

TABLE 316            HEALTH CATALYST: COMPANY OVERVIEW                 292

TABLE 317            HEALTH CATALYST: SOLUTIONS OFFERED                 293

TABLE 318            HEALTH CATALYST: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025              294

TABLE 319            HEALTH CATALYST: DEALS, JANUARY 2022–SEPTEMBER 2025              294

TABLE 320            SYMPLR: COMPANY OVERVIEW 297

TABLE 321            SYMPLR: SOLUTIONS OFFERED 297

TABLE 322            SYMPLR: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                298

TABLE 323            SYMPLR: DEALS, JANUARY 2022–SEPTEMBER 2025        298

TABLE 324            CLARITY GROUP, INC.: COMPANY OVERVIEW                 300

TABLE 325            CLARITY GROUP, INC.: SOLUTIONS OFFERED                 300

TABLE 326            PERFORMANCE HEALTH PARTNERS: COMPANY OVERVIEW          301

TABLE 327            PERFORMANCE HEALTH PARTNERS: SOLUTIONS OFFERED   301

TABLE 328            PERFORMANCE HEALTH PARTNERS: DEALS, JANUARY 2022–SEPTEMBER 2025                302

TABLE 329            MORCARE: COMPANY OVERVIEW            303

TABLE 330            MORCARE: SOLUTIONS OFFERED            303

TABLE 331            RISKQUAL TECHNOLOGIES, INC.: COMPANY OVERVIEW          304

TABLE 332            RISKQUAL TECHNOLOGIES, INC.: SOLUTIONS OFFERED             304

TABLE 333            PRISTA CORPORATION: COMPANY OVERVIEW                 305

TABLE 334            PRISTA CORPORATION: SOLUTIONS OFFERED                 305

TABLE 335            SAFEQUAL: COMPANY OVERVIEW           306

TABLE 336            SAFEQUAL: SOLUTIONS OFFERED           306

TABLE 337            IQVIA: COMPANY OVERVIEW     307

TABLE 338            IQVIA: SOLUTIONS OFFERED     308

TABLE 339            IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025              309

TABLE 340            IQVIA: DEALS, JANUARY 2022–SEPTEMBER 2025                 309

TABLE 341            INOVALON: COMPANY OVERVIEW          310

TABLE 342            INOVALON: SOLUTIONS OFFERED          310

TABLE 343            INOVALON: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025              311

TABLE 344            NAVEX GLOBAL, INC.: COMPANY OVERVIEW                 312

TABLE 345            NAVEX GLOBAL, INC.: SOLUTIONS OFFERED                 312

TABLE 346            NAVEX GLOBAL, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                313

TABLE 347            NAVEX GLOBAL, INC.: DEALS, JANUARY 2022–SEPTEMBER 2024              314

TABLE 348            NAVEX GLOBAL, INC.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025   314

TABLE 349            CENSINET: COMPANY OVERVIEW            315

TABLE 350            CENSINET: SOLUTIONS OFFERED            315

TABLE 351            CENSINET: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                316

TABLE 352            AMERICAN DATA NETWORK: COMPANY OVERVIEW          317

TABLE 353            AMERICAN DATA NETWORK: SOLUTIONS OFFERED             317

TABLE 354            ARVENTA: COMPANY OVERVIEW             318

TABLE 355            ARVENTA: SOLUTIONS OFFERED             318

TABLE 356            COMPLIANCEQUEST: COMPANY OVERVIEW                 319

TABLE 357            COMPLIANCEQUEST: SOLUTIONS OFFERED                 319

TABLE 358            COMPLIANCEQUEST: SOLUTION LAUNCHES AND ENHANCEMENTS,

JANUARY 2022–SEPTEMBER 2025                320

TABLE 359            COMPLIANCEQUEST: DEALS, JANUARY 2022–SEPTEMBER 2025              320

TABLE 360            RADAR HEALTHCARE INC: COMPANY OVERVIEW          321

TABLE 361            RADAR HEALTHCARE INC: SOLUTIONS OFFERED             321

TABLE 362            PASCAL METRICS INC.: COMPANY OVERVIEW                 322

TABLE 363            PASCAL METRICS INC.: SOLUTIONS OFFERED                 322

TABLE 364            OMNIGO: COMPANY OVERVIEW               323

TABLE 365            LOGICMANAGER, INC.: COMPANY OVERVIEW                 324

TABLE 366            DEXUR: COMPANY OVERVIEW  325

TABLE 367            HEALTHCARE GRC PTE. LTD.: COMPANY OVERVIEW          326

TABLE 368            NOSOTECH INC.: COMPANY OVERVIEW                 327

LIST OF FIGURES

FIGURE 1              PATIENT SAFETY AND RISK SOFTWARE MARKET SEGMENTATION

AND REGIONAL SCOPE 33

FIGURE 2              RESEARCH DESIGN         37

FIGURE 3              PRIMARY SOURCES         40

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE):

BY COMPANY TYPE, DESIGNATION, AND REGION            42

FIGURE 5              SUPPLY-SIDE MARKET ESTIMATION      43

FIGURE 6              PATIENT SAFETY AND RISK SOFTWARE MARKET:

REVENUE ESTIMATION APPROACH         43

FIGURE 7              BOTTOM-UP APPROACH: END-USER SPENDING ON PATIENT SAFETY

AND RISK SOFTWARE    45

FIGURE 8             CAGR PROJECTIONS FROM MARKET DYNAMICS, 2025–2030              47

FIGURE 9              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 47

FIGURE 10            TOP-DOWN APPROACH                48

FIGURE 11            DATA TRIANGULATION METHODOLOGY                 49

FIGURE 12            PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION,

2025 VS. 2030 (USD MILLION)      52

FIGURE 13            PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE,

2025 VS. 2030 (USD MILLION)      53

FIGURE 14            PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      54

FIGURE 15            PATIENT SAFETY AND RISK SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT   55

FIGURE 16            GROWING HEALTHCARE EXPENDITURE AND RISING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE MARKET               56

FIGURE 17            HEALTHCARE PROVIDERS AND US LED NORTH AMERICAN MARKET IN 2024        57

FIGURE 18            INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       58

FIGURE 19            EMERGING MARKETS TO HAVE HIGHER GROWTH THAN DEVELOPED MARKETS DURING FORECAST PERIOD                59

FIGURE 20            PATIENT SAFETY AND RISK SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    60

FIGURE 21            REPORTS SUBMITTED TO PENNSYLVANIA’S PATIENT SAFETY REPORTING SYSTEM BY HOSPITALS, 2022–2024        62

FIGURE 22            REPORTS SUBMITTED TO PENNSYLVANIA’S PATIENT SAFETY REPORTING SYSTEM BY NON-HOSPITALS, 2022–2024              62

FIGURE 23            REVENUE SHIFT IN PATIENT SAFETY AND RISK SOFTWARE MARKET       70

FIGURE 24            PATIENT SAFETY AND RISK SOFTWARE MARKET: VALUE CHAIN ANALYSIS           72

FIGURE 25            PATIENT SAFETY AND RISK SOFTWARE MARKET: ECOSYSTEM ANALYSIS              74

FIGURE 26            PATIENT SAFETY AND RISK SOFTWARE MARKET: INVESTMENT

AND FUNDING SCENARIO           76

FIGURE 27            PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION

AND TOP APPLICANT ANALYSIS, JANUARY 2022–SEPTEMBER 2025        79

FIGURE 28            PATIENT SAFETY AND RISK SOFTWARE MARKET: PATENT ANALYSIS,

JANUARY 2015–SEPTEMBER 2025                80

FIGURE 29            PATIENT SAFETY AND RISK SOFTWARE MARKET:

PORTER’S FIVE FORCES ANALYSIS           92

FIGURE 30            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS     94

FIGURE 31            KEY BUYING CRITERIA FOR TOP THREE END USERS   95

FIGURE 32            MARKET POTENTIAL OF AI/GENERATIVE AI IN PATIENT SAFETY

AND RISK SOFTWARE    99

FIGURE 33            IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS   101

FIGURE 34            NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT               142

FIGURE 35            ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT               185

FIGURE 36            REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, 2020–2024 (USD MILLION) 262

FIGURE 37            MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY

AND RISK SOFTWARE MARKET, 2024       263

FIGURE 38            PATIENT SAFETY AND RISK SOFTWARE MARKET: BRAND/SOFTWARE COMPARISON       266

FIGURE 39            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS            267

FIGURE 40            EV/EBITDA OF KEY VENDORS   267

FIGURE 41            PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024                 269

FIGURE 42            PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY FOOTPRINT             270

FIGURE 43            PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024        276

FIGURE 44            HEALTH CATALYST: COMPANY SNAPSHOT (2024)    293

FIGURE 45            IQVIA: COMPANY SNAPSHOT (2024)        308

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 精密林業市場規模、シェア、動向、2030年までの世界予測 2025-11-05
• フィールドサービス管理市場規模、シェア、動向、2030年までの世界予測 2025-11-05
• 採血装置市場規模、シェア、動向、2030年までの世界予測 2025-11-04
• 車載半導体市場規模、シェア、動向、2030年までの世界予測 2025-11-04
• データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31

MarketsandMarkets  出版レポート一覧